A small molecule NNMT inhibitor studied for increasing cellular energy expenditure and reducing fat accumulation.
A fusion protein blocking activin receptor signalling, studied for dramatic effects on muscle mass and bone density.
A neuromodulating hexapeptide studied for reducing expression lines through muscle relaxation mechanisms.
A synthetic nootropic peptide studied for cognitive enhancement, BDNF modulation, and neuroprotection.
A proapoptotic peptide studied for selectively targeting blood vessels feeding white adipose tissue.
A copper tripeptide studied for hair follicle stimulation and scalp tissue biology research.
An AMPK activator studied as an exercise mimetic with applications in metabolic and endurance research.
Higher-dose HGH-derived fat-targeting peptide for extended research capacity per vial.
A modified fragment of human growth hormone studied for fat metabolism without affecting blood sugar or IGF-1 levels.
A non-haematopoietic EPO peptide analogue studied for neuropathic pain, anti-inflammatory activity, and tissue protection.
Mid-range ARA-290 format for neuroprotection and anti-inflammatory research protocols.
A single-chain relaxin analogue studied for anti-fibrotic activity and tissue remodelling research.
A premium triple-peptide healing and regeneration blend combining repair, recovery, and anti-aging mechanisms.
The most popular recovery research blend — combining BPC-157 and TB-500 for comprehensive tissue repair studies.
Double-strength BPC-157 vial for extended healing and cytoprotection research protocols.
